Drug Information

Drug General Information
Drug ID
D07SWU
Former ID
DCL000250
Drug Name
TM30338
Indication Obesity [ICD9: 278; ICD10:E66] Discontinued in Phase 2 [548209]
Company
7TMPharma.
Target and Pathway
Target(s) Neuropeptide Y receptor type 2 Target Info Modulator
Neuropeptide Y receptor type 4 Target Info Modulator
KEGG Pathway Neuroactive ligand-receptor interactionhsa04080:Neuroactive ligand-receptor interaction
Reactome Peptide ligand-binding receptors
G alpha (i) signalling eventsR-HSA-375276:Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
GPCR ligand binding
GPCR downstream signalingWP455:GPCRs, Class A Rhodopsin-like
GPCR downstream signaling
References
Ref 548209Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023122)

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.